GlassScriptPhysician profile
Thomas Norman Steele
NPI 1477085686
$2,184.67
in general payments reported to CMS, 2019-2025
12 companies · $1,386 in 2025
The $1,386 reported for 2025 was more than what 79% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $97.08 · 2023: $160 · 2024: $541 · 2025: $1,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,087.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $476.67 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Polynovo North America LLC | $291.92 | 2025 | Novosorb Btm |
| Davol INC. | $251.65 | 2025 | Phasix Mesh |
| Mentor Worldwide LLC | $206.60 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Axogen | $155.79 | 2025 | |
| Sanara Medtech INC. | $153.49 | 2025 | Celleraterx |
| Solventum Corporation | $146.87 | 2025 | Prevena |
| Stryker Corporation | $120.49 | 2024 | 1788 |
| Baxter Healthcare | $110.50 | 2024 | Floseal |
| Innovation Technologies INC | $110.49 | 2023 | Irrisept |
| Integra Lifesciences Corporation | $97.08 | 2021 | |
| Checkpoint Surgical, INC | $63.12 | 2025 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.